MedTech News
FDA Expands Indication for Levita Magnetics’ MARS® System in Minimally Invasive Surgery
Magnetic-Assisted Robotic Platform Now Approved for Bariatric and Hiatal Hernia Procedures, Broadening Access to Scar-Reducing Surgical Innovation
Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
Johnson & Johnson MedTech (NYSE: JNJ)+
announced today that it launched new variable angle optimized locking technology (VOLT) plating systems.
CereVasc Receives Health Canada Investigational Testing Authorization for STRIDE Clinical Trial of the eShunt® System
BOSTON, June 18, 2025 /PRNewswire/ — CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced today that it has received Investigational Testing Authorization (ITA) from Health Canada to conduct the STRIDE trial, a clinical study evaluating CereVasc’s eShunt System as a treatment for normal pressure hydrocephalus (NPH).
Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence
SAN JOSE, Calif., June 18, 2025 /PRNewswire/ — Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system for the treatment of urinary urge incontinence (UUI).
Expanding Innovations Receives FDA Clearance for N-GAGE™ Lumbar Plate System
MOUNTAIN VIEW, Calif., June 18, 2025 /PRNewswire/ — Expanding Innovations™ (EI), a rapidly growing spine company specializing in NON-SCREW-based Expandable Technology, today announced U.S. FDA 510(k) clearance for its N-GAGE™ Lumbar Plate System—the company’s first spinal fixation platform as it continues to broaden its procedure-based solutions.
Palm-sized device detects disease markers in under 45 minutes without additional lab equipment
Scientists from the National University of Singapore (NUS) have developed NAPTUNE (Nucleic Acids and Protein biomarkers Testing via Ultra-sensitive Nucleases Escalation), a point-of-care assay that identifies trace amounts of disease-related genetic material, including nucleic acid and protein markers, in less than 45 minutes. Importantly, it accomplished this without the need for laboratory equipment or complex procedures.
Getting beyond the gut: AI tool reveals hidden health risks for people with inflammatory bowel disease
University of Alberta researchers have created a new tool to help doctors and patients recognize other illnesses commonly associated with inflammatory bowel disease (IBD), including autoimmune, mental health and heart problems.
ChoiceSpine™ Launches Surgical App Integration with eCential Robotics Platform
New ChoiceSpine™ App Enhances Precision and Efficiency in Spine Surgery with Op.n™ Robotic and Navigation Technology